Low-cost scoring system informs HBV treatment eligibility in resource-limited countries

SAN DIEGO — A new, low-cost scoring system called TREAT-B accurately determined treatment eligibility for patients with hepatitis B virus, particularly where DNA assays are unavailable, according to research.“Major international guidelines have recommended the criteria for initiating treatment in patients with chronic hepatitis B infection. However, the hepatitis B DNA assay is not widely accessible and affordable, particularly in low- and middle-income countries. A simple score to indicate hepatitis B treatment eligibility is urgently needed to overcome the barriers for treatmentRead More

Generated by Feedzy